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ABSTRACT: Bacterial DD-peptidases are the targets of the β-lactam
antibiotics. The sharp increase in bacterial resistance toward these
antibiotics in recent years has stimulated the search for non-β-lactam
alternatives. The substrates of DD-peptidases are elements of peptidogly-
can from bacterial cell walls. Attempts to base DD-peptidase inhibitor
design on peptidoglycan structure, however, have not been particularly
successful to date because the speciﬁc substrates for most of these
enzymes are unknown. It is known, however, that the preferred substrates
of low-molecular mass (LMM) class B and C DD-peptidases contain the
free N-terminus of the relevant peptidoglycan. Two very similar LMMC enzymes, for example, the Actinomadura R39 DD-
peptidase and Bacillus subtilis PBP4a, recognize a D-α-aminopimelyl terminus. The peptidoglycan of B. subtilis in the vegetative
stage, however, has the N-terminal D-α-aminopimelyl carboxylic acid amidated. The question is, therefore, whether the DD-
peptidases of B. subtilis are separately speciﬁc to carboxylate or carboxamide or have dual speciﬁcity. This paper describes an
investigation of this issue with B. subtilis PBP4a. This enzyme was indeed found to have a dual speciﬁcity for peptide substrates,
both in the acyl donor and in the acyl acceptor sites. In contrast, the R39 DD-peptidase, from an organism in which the
peptidoglycan is not amidated, has a strong preference for a terminal carboxylate. It was also found that acyl acceptors, reacting
with acyl−enzyme intermediates, were preferentially D-amino acid amides for PBP4a and the corresponding amino acids for the
R39 DD-peptidase. Examination of the relevant crystal structures, aided by molecular modeling, suggested that the expansion of
speciﬁcity in PBP4a accompanies a change of Arg351 in the R39 enzyme and most LMMC DD-peptidases to histidine in PBP4a
and its orthologs in other Bacillus sp. This histidine, in neutral form at pH 7, appeared to be able to favorably interact with both
carboxylate and carboxamide termini of substrates, in agreement with the kinetic data. It may still be possible, in speciﬁc cases, to
combat bacteria with new antibiotics based on particular elements of their peptidoglycan structure.
DD-Peptidases catalyze the ﬁnal step(s) in bacterial cell wall
biosynthesis. These enzymes, therefore, are important antibiotic
targets and do, in fact, represent the site of action of the β-
lactams.1,2 They are known to catalyze the peptidoglycan cross-
linking reaction of Scheme 1, an amide aminolysis (trans-
peptidase) reaction involving a covalent acyl−enzyme inter-
mediate. Although it is clear that the substrates of these
enzymes must be elements of peptidoglycan, the source of their
individual speciﬁcity is, in general, not understood.3,4
The issue is complicated by the presence in bacteria of a
variety of DD-peptidases with apparently diﬀerent roles in cell
wall construction, and acting at diﬀerent times in the cell
cycle.5,6 They are usually subdivided into a high-molecular mass
(HMM) group, with subclasses A and B, and a low-molecular
mass (LMM) group, with subclasses A−C.7 The former act as
transpeptidases (Scheme 1), are essential to bacterial survival,
and represent the killing sites of the β-lactam antibiotics. The
LMM group is believed to contain carboxypeptidases and
endopeptidases, which are engaged in peptidoglycan matura-
tion and degradation and are nonessential to bacterial survival,
in the short term at least, although they are also inhibited by β-
lactams.
A representative example of general peptidoglycan structure
(stem peptide dimer) is shown in Figure 1. In this ﬁgure, 1
represents a peptidoglycan dimer and (a) and (b) represent the
two structural variants, carboxylate and carboxamide, discussed
in detail below. One might imagine that the DD-peptidases
would show some recognition of elements of this structure. The
results of experiments conducted in vitro with individual
puriﬁed DD-peptidases are decidedly ambivalent overall.3 In
general, puriﬁed HMM DD-peptidases show no signiﬁcant
aﬃnity for any part of 1 or catalyze any reaction of it at
biologically signiﬁcant rates. Certain LMMA DD-peptidases
catalyze the carboxypeptidase reaction of D-alanine-terminating
peptides but, in general, show no signiﬁcant aﬃnity for any part
of 1. LMMB and LMMC enzymes, however, have been shown
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to exhibit strong aﬃnity for the stem peptide N-terminus
appropriate to the particular organism from which they were
derived.4,8,9 This result is seen in the kinetics of turnover of
speciﬁc peptide substrates and the aﬃnity of speciﬁc inhibitors
such as β-lactams and boronic acids. The structural bases of
these speciﬁcities have been revealed by crystal structures of
various complexes of the enzymes with these compounds.10−12
One LMMC DD-peptidase in which these issues have been
studied in some detail is PBP4a of Bacillus subtilis. This enzyme
has been shown to have considerable speciﬁcity toward peptide
2 (kcat/Km = 2.2 × 10
4 s−1 M−1) and is strongly inhibited by
boronic acid 3 (Ki = 9 nM).
4 The structural basis of this
speciﬁcity has been revealed by crystallography.13
It has also been shown, however, that during the vegetative
stage of growth, B. subtilis cell walls contain amidated meso-
diaminopimelic acid,14,15 and thus, the peptidoglycan structure
would be represented by 1b. On the other hand, in B. subtilis
spores, the predominant peptidoglycan is not amidated, as in
1a.16 Peptidoglycan containing amidated diaminopimelic acid is
not uncommon and, in some cases, has established function.17
The actual in vivo role of B. subtilis PBP4a is not known,
although it is apparently expressed in the late vegetative stage of
growth18 and thus, as an endopeptidase, may be faced with 1b
as a substrate. On the other hand, if it is also active during
construction of the spore wall, it might also be expected to
hydrolyze 1a. The same issue must face other B. subtilis DD-
peptidases or penicillin-binding proteins (PBPs). B. subtilis
carries an extensive array of PBPs, some devoted to the
vegetative stage and others expressed during spore formation.19
The speciﬁcity of these enzymes for amidated versus non-
amidated peptidoglycan is, in general, not known. In this paper,
we explore the speciﬁcity of B. subtilis PBP4a for the speciﬁc
amidated acyl-donor and acyl-acceptor substrates 4 and 5, as
expressed in steady state kinetics. The analogy of the latter
substrate to an amidated penicillin is also explored.
■ MATERIALS AND METHODS
D-Amino acids and D-amino acid amides were commercial
products (Sigma, ChemImpex) and used as received, except D-
lysinamide, which was prepared as described in the Supporting
Information. The synthesis of 2 in this laboratory has been
previously described.20 Penicillin V (phenoxymethylpenicillin)
was purchased from Sigma and its amide synthesized in this
laboratory according to the method of Johnson21 by E.
Baukanas. N-(Phenylacetyl)glycyl-D-thiolactate was synthesized
as previously described.22
Synthesis. The synthesis of 4 is outlined in Scheme 2, and
the experimental details are given below.
D-6-(N,N-Dibenzylamino)-6-(benzyloxycarbonyl)-trans-
hex-2-enoic Acid Ethyl Ester (7). To a stirred solution of 6
(2.84 g, 7 mmol, 1 equiv)12 in dry THF (20 mL) (under an
inert atmosphere) was added (carbethoxymethylene)-
triphenylphosphorane (3.2 g, 9.2 mmol, 1.3 equiv) at room
temperature. The reaction mixture was stirred for 4 h, after
which solvent was evaporated. The crude product was puriﬁed
by chromatography on silica gel (9.5:0.5 hexane:ethyl acetate),
yielding the product 7 as a colorless oil (1.62 g, 60% yield): 1H
NMR (CDCl3, 300 MHz) δ 1.27 (t, J = 6.9 Hz, 3H), 1.86 (m,
2H), 2.05 (m, 1H), 2.32 (m, 1H), 3.35 (t, J = 7.5 Hz, 2H), 3.50,
3.88 (AB q, J = 15 Hz, 4H), 4.15 (q, J = 7.2 Hz, 2H), 5.16, 5.26
(AB q, J = 10.8 Hz, 2H), 5.62 (d, J = 16 Hz, 1H), 6.75 (quint, J
= 7.2 Hz, 1H), 7.2−7.45 (m, 15H).
D-α-Aminopimelic Acid Ethyl Ester (8). To a solution of 7
(1.02 g, 2.3 mmol, 1.0 equiv) in a mixture of methanol (30 mL)
and ethyl acetate (5 mL) was added 10% Pd on activated
carbon (Pd/C) (260 mg). The hydrogenation reaction was
conducted at 50 psi H2 at room temperature for 16 h. Pd/C
was removed by ﬁltration through a Celite pad. The ﬁltrate was
evaporated leaving behind an oﬀ-white solid, which was dried
under reduced pressure to give 8 (335 mg, 78%): 1H NMR
(CD3OD, 300 MHz) δ 1.21 (t, J = 6.9 Hz, 3H), 1.42 (m, 2H),
1.62 (m, 2H), 1.80 (m, 2H), 2.34 (t, J = 7.5 Hz, 2H), 3.5 (m,
1H), 4.2 (q, J = 7.2 Hz, 2H).
(Z)-D-α-Aminopimelic Acid Ethyl Ester (9). To a stirred
solution of 8 and Na2CO3 in a water/dioxane (1:1) mixture (20
mL) at ice temperature was added benzyl chloroformate (0.35
mL, 3.3 mmol, 2.0 equiv) in dioxane (3 mL) dropwise over 10
min. The reaction mixture was then brought to room
temperature and stirred overnight. The mixture was extracted
with ether (3 × 20 mL), and the pH of the aqueous layer was
adjusted to 1.0 by addition of 1.0 M HCl. The acidiﬁed layer
was extracted with ethyl acetate (5 × 50 mL) and separated.
The combined organic layers were dried over Na2SO4 and
evaporated to dryness. The residue was dried further under
reduced pressure, and the resulting sticky gum was puriﬁed by
column chromatography on silica gel (4:3 hexane:ethyl acetate)
to yield 9 as a colorless oil (0.5 g, 95% yield): 1H NMR (D6−
DMSO, 300 MHz) δ 1.16 (t, J = 7.2 Hz, 3H), 1.31 (m, 2H),
1.49 (m, 2H), 1.65 (m, 2H), 2.26 (t, J = 7.5 Hz, 2H), 3.9 (m,
1H), 4.02 (q, J = 7.5 Hz, 2H), 5.05 (s, 2H), 7.35 (s, 5H), 7.6
(d, J = 8.1 Hz, 2H).
D - 6 - B e n z y l o x y c a r b o n y l am i n o - 6 - [ N - ( 2 ′ , 4 ′ -
dimethoxybenzyl)carbamoyl]hexanoic Acid Ethyl Ester (10).
Compound 9 (0.5 g, 1.48 mmol, 1.0 equiv) in DMF (12 mL)
was added by syringe into a round-bottom ﬂask containing
HATU (0.76 g, 2.0 mmol, 1.35 equiv) maintained under a
nitrogen atmosphere with constant stirring. The ﬂask was
cooled with ice, and 2,4-dimethoxybenzylamine (0.3 mL, 2.0
Figure 1. Stem peptide dimer of B. subtilis showing the sites of
amidation and DD-peptidase cleavage. The structural variants addressed
in this paper are (a) carboxylate and (b) carboxamide.
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mmol, 1.35 equiv) was added. DIPEA (0.64 mL, 3.7 mmol, 2.5
equiv) was then added dropwise over 20 min. The reaction
mixture was subsequently brought to room temperature and
stirred overnight. The solvent, DMF, was removed by rotary
evaporation, and the residue was extracted with ethyl acetate.
This solution was washed with 0.1 M HCl (20 mL), water, and
ﬁnally brine. The organic layer was separated, dried over
Na2SO4, and evaporated to dryness. The residual yellow oil was
puriﬁed by column chromatography on silica gel (3:7
hexane:ethyl acetate) to yield 10 as a colorless solid (440 mg,
70% yield): 1H NMR (D6− DMSO, 300 MHz) δ 1.16 (t, J = 7.2
Hz, 3H), 1.23 (m, 2H), 1.49 (m, 2H), 1.65 (m, 2H), 2.26 (t, J =
7.5 Hz, 2H), 3.73 (s, 3H), 3.76 (s, 3H), 3.9 (m, 1H), 4.02 (q, J
= 7.2 Hz, 2H), 4.15 (m, 2H), 5.02 (s, 2H), 6.45 (d, J = 7.8
Hz,1H), 6.53 (s, 1H), 7.04 (d, J = 8.4 Hz, 2H), 7.38 (m, 5H),
8.1 (m, 1H); ESI/MS(+) m/z 487.92 (M + 1), 510.27 (M +
23).
D - 6 - B e n z y l o x y c a r b o n y l am i n o - 6 - [ N - ( 2 ′ , 4 ′ -
dimethoxybenzyl)carbamoyl]hexanoic Acid (11). LiOH (17
mg, 0.7 mmol, 1.0 equiv) was added to compound 10 (340 mg,
0.7 mmol, 1.0 equiv) dissolved in a water/THF (1:1) mixture
(20 mL) at 5 °C. The reaction mixture was stirred at 5−10 °C
until TLC showed complete conversion of the starting material.
After completion of the reaction, THF was removed by
evaporation and the pH of the aqueous layer adjusted to 1.0 by
addition of 1.0 M HCl. The aqueous layer was then extracted
with ethyl acetate (4 × 50 mL) and separated. The combined
organic layers were dried over Na2SO4 and evaporated to
dryness. The crude product was puriﬁed by column
chromatography on silica gel (9.3:0.7 DCM:MeOH) to yield
11 as a colorless solid (300 mg, 85% yield): 1H NMR (CD3OD,
300 MHz) δ 1.34 (m, 2H), 1.59 (m, 2H), 1.60 (m, 2H), 2.24
(t, J = 7.5 Hz, 2H), 3.76 (s, 3H), 3.78 (s, 3H), 4.05 (m, 1H),
4.3 (m, 2H), 5.07 (s, 2H), 6.43 (d, J = 7.8 Hz, 1H), 6.49 (s,
1H), 7.12 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 7.8 Hz, 2H), 7.36
(m, 5H), 8.1 (m, 1H); ESI/MS(−) m/z 457.00 (M − 1).
D - 6 - B e n z y l o x y c a r b o n y l am i n o - 6 - [ N - ( 2 ′ , 4 ′ -
dimethoxybenzyl)carbamoyl]hexanoyl-D-alanyl-D-alanine
Benzyl Ester (13). To a solution of 11 (200 mg, 0.44 mmol, 1.0
equiv) in DMF (3 mL) were added N-hydroxysuccinimide (63
mg, 0.55 mmol, 1.25 equiv) and 1-ethyl-3-[3-(dimethylamino)-
propyl]carbodiimide (105 mg, 0.55 mmol, 1.25 equiv) at ice
temperature. The reaction mixture was brought to room
temperature and stirred for 20 h. To this mixture was added a
solution of D-alanyl-D-alanine benzyl ester 124 (0.24 g, 0.66
mmol, 1.5 equiv) in DMF (3 mL) followed by the dropwise
addition of DIPEA (0.23 mL, 1.3 mmol, 3.0 equiv). The
mixture was stirred overnight, after which DMF was removed
by evaporation under vacuum. Water was added to the residue,
and the solid formed was collected by ﬁltration and dried under
vacuum. The residual solid was recrystallized from 2-propanol
to yield 13 as a colorless solid (170 mg, 58% yield): 1H NMR
(D6− DMSO, 300 MHz) δ 1.07 (d, J = 6.9 Hz, 3H), 1.12 (d, J =
6.9 Hz, 3H), 1.28 (m, 2H), 1.43 (m, 2H), 1.60 (m, 2H), 2.06
(t, J = 6.8 Hz, 2H), 3.37 (s, 3H), 3.39 (s, 3H), 3.98 (m, 1H),
4.10 (m, 1H), 4.3 (m, 2H), 5.02 (s, 2H), 5.10 (s, 2H), 6.46 (d, J
= 8.4 Hz, 1H), 6.52 (s, 1H), 7.04 (d, J = 8.4 Hz, 2H), 7.36 (m,
5H), 7.93 (d, J = 8.1 Hz, 1H), 8.1 (m, 1H), 8.34 (d, J = 6.0 Hz,
1H); ESI/MS(+) m/z 691.0 (M + 1), 713.43 (M + 23).
D-6-Benzyloxycarbonylamino-6-carbamoylhexanoyl-D-
alanyl-D-alanine Benzyl Ester (14). TFA (1.5 mL) was added
to 13 (40 mg, 0.06 mmol) in a round-bottom ﬂask at room
Scheme 2
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temperature, and the solution was stirred for 3.5 h. TLC
monitoring conﬁrmed the disappearance of the starting
material. TFA was removed by evaporation, and the pink
solid thus obtained was washed with ether until the pink color
was completely removed. The crude product was puriﬁed by
preparative TLC on silica gel with 7.5% MeOH in DCM as the
eluent, yielding 14 as a colorless solid (28 mg, 86% yield): 1H
NMR (CD3OD, 300 MHz) δ 1.27 (d, J = 7.2 Hz, 3H), 1.37 (d,
J = 7.5 Hz, 3H), 1.43 (m, 2H), 1.61 (m, 2H), 1.79 (m, 2H),
2.20 (t, J = 6.9 Hz, 2H), 4.05 (m, 1H), 4.31 (m, 2H), 4.45 (m,
1H), 5.07 (s, 2H), 5.14 (d, J = 5.4 Hz, 2H), 7.39 (s, 10H); ESI/
MS(+) m/z 541.0 (M + 1), 563.40 (M + 23).
D-6-Amino-6-carbamoylhexanoyl-D-alanyl-D-alanine (4).
To a solution of 14 (28 mg, 0.05 mmol) in methanol (20
mL) was added 10% Pd/C (10 mg). The hydrogenation
reaction was conducted at 40 psi H2 at room temperature for 5
h. Pd/C was removed by ﬁltration through a Celite pad. The
ﬁltrate was evaporated, leaving behind an oﬀ-white solid, which
was dried under reduced pressure to give 4 (7 mg, 50% yield):
1H NMR (D2O) δ 1.2 (m, 6H), 1.30 (m, 2H), 1.50 (m, 2H),
1.75 (m, 2H), 2.16 (t, J = 7 Hz, 2H), 3.85 (t, J = 6.6 Hz, 1H),
4.01 (q, J = 7.6 Hz, 1H), 4.14 (q, J = 7.6 Hz, 1H); high-
resolution ESI/MS(+) m/z 317.1816 (M + 1), calcd for
C13H25N4O5 317.1825.
Enzyme Kinetics. Steady state kinetics experiments were
conducted under conditions previously established to generate
high stable activity of Actinomadura R39 DD-peptidase and B.
subtilis PBP4a:4 20 mM sodium phosphate (pH 7.5) at 25 °C.
Measurements of enzyme activity with peptides 4 and 5 were
determined spectrophotometrically where the loss of the
peptide bond was monitored at wavelengths between 215
and 235 nm. Initial rates were ﬁt to the Henri−Michelis−
Menten equation by a nonlinear squares procedure to yield
values of kcat and Km. The range of peptide substrate
concentrations employed was typically 0−1.0 or 0−2.0 mM,
and enzyme concentrations were typically 0.10−0.25 μM. In
cases where substrate concentrations approaching Km were not
achieved, values of kcat/Km were obtained by nonlinear least-
squares exponential ﬁts to the progress curve. In the case of the
Actinomadura R39 DD-peptidase, the Km of the peptide
substrate 4 was determined as the Ki value from a competition
experiment in which N-(phenylacetyl)glycyl-D-thiolactate, 15,
was the spectrophotometric substrate (245 nm; Δε = 2500
cm−1 M−1; Km = 38.4 μM). Kinetics of aminolysis of 15 by
amino acids and amino acid amides were conducted as
previously described.23 Rate constants of inactivation of the
enzymes by the penicillins 16 and 17 were obtained from
similar experiments where total progress curves were ﬁt to
Scheme 3 with Dynaﬁt.24 Concentrations of enzyme, substrate
(15), 16, and 17 in these experiments were 0.14 μM, 0.5 mM,
0−0.30 μM, and 0−0.60 μM, respectively, for the R39 DD-
peptidase and 0.17 μM, 0.5 mM, 0−0.10 μM, and 0−6.0 μM,
respectively, for PBP4a. Compounds 20 and 21 were generated
from the hydrolysis of 2 and 4, respectively, in the presence of
PBP4a, and studied as inhibitors of this enzyme in situ as a
function of pH. Buﬀers for the latter experiments were 20 mM
MES (pH 6.0), 20 mM MOPS (pH 7.5), and 20 mM TAPS
(pH 8.8).
Computational Methods. Crystal structures of Actino-
madura R39 DD-peptidase [Protein Data Bank (PDB) entry
2XDM] and B. subtilis PBP4a (PDB entry 2J9P) with speciﬁc
ligands bound in the active site were used as the starting point
for model building and computations with Discovery Studio
version 2.5 (Accelrys). Tetrahedral intermediate structures of
the enzyme−substrate reaction were modeled with D-alanine or
D-alaninamide as the leaving group. A pH of 7.0 was set, with
positive charge on Lys52 (R39) and Lys55 (PBP4a) and
negative charge on Asp142 (Asp145), whereas His352 (PBP4a)
was either charged or uncharged depending on the environ-
ment desired. The CHARMm force ﬁeld was employed for all
the computations.
In each case, the enzyme−substrate complex was hydrated
with a 20 Å sphere of water molecules centered at the active site
serine. The hydrated structure was energy-minimized using a
steepest descent algorithm (250 steps), followed by the
conjugate gradient method for a total of 1000 steps. The
energy-minimized structures were heated to 300 K in 10000
steps (10 ps) with coordinates saved every 100 steps. The
output structure of the equilibration run was then subjected to
a 1.0 ns production run at 300 K. Several structures were
selected from the output of each production run, and each of
these was energy-minimized using the protocol mentioned
above.
■ RESULTS AND DISCUSSION
The substrate speciﬁcity of bacterial DD-peptidases in terms of
the structure of their presumed substrate, represented in Figure
1, is a matter of considerable interest because of its relevance to
antibiotic design. Considering the reactions catalyzed, trans-
peptidase, endopeptidase, and carboxypeptidase (Figure 1), and
the general mechanism of the reaction (Scheme 1), it is clear
that there are two elements of substrate speciﬁcity, that for the
acyl donor and that for the acyl acceptor.
PBP4a of B. subtilis is a LMM class C DD-peptidase, thought
likely to be an endopeptidase in vivo.4,25 The substrate
speciﬁcity of this enzyme is particularly interesting because of
the variable amidation of diaminopimelic acid exhibited in B.
subtilis peptidoglycan, as described in the introductory section.
To examine this issue, we ﬁrst assessed the reactivity of PBP4a
with substrates 2, 4, and 5. As a control, the Actinomadura R39
DD-peptidase, another LMMC enzyme, was employed; as far as
we are aware, Actinomadura peptidoglycan does not contain
amidated diaminopimelic acid.9
The synthesis of 4 was achieved as outlined in Scheme 2.
The orthogonally protected D-α-aminopimelic acid derivative
10 was obtained from the previously described versatile
intermediate 6. The ethyl ester 10 was then hydrolyzed to
produce the acid 11, which was coupled to D-alanyl-D-alanine
benzyl ester 12, yielding the protected tripeptide 13. The
carboxamide group of 13, protected as an N-(2,4-dimethox-
ybenzyl) derivative,26 was deprotected with triﬂuoroacetic acid
and the remaining benzyl groups by hydrogenation to aﬀord
the required product 4. The more straightforward synthesis of 5
Scheme 3
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is outlined in Scheme 4 and described in detail in the
Supporting Information.
Both the R39 DD-peptidase and PBP4a catalyzed hydrolysis
of the C-terminal amino acid residue of 4 and 5, D-alanine and
D-alaninamide, respectively, as demonstrated by electrospray
mass spectra of completed reaction mixtures (not shown).
Steady state rate parameters obtained from kinetics studies of
this reaction are presented in Table 1. These data show that the
R39 enzyme is strongly speciﬁc for the diacid 2 with
signiﬁcantly less reactivity with the monoamides 4 and 5 and,
in particular, with 5 where the amide would be in the acceptor
site. The diﬀerences seem to be largely in the Km parameter,
suggesting diﬀerences in direct aﬃnity for the active site,
although it should be noted that whether acyl−enzyme
intermediate formation or breakdown is rate-determining in
the presence of saturating substrate is currently unknown. In
the case of PBP4a, there is little diﬀerence in speciﬁcity for 2, 4,
and 5, suggesting that carboxylate and amide react equally well
in both sites. The common relatively high Km is notably
diﬀerent from the situation with the R39 enzyme. It has been
suggested that this reﬂects a need for a protein conformational
change accompanying the reactions of PBP4a, perhaps deriving
from the presence of unreactive conformers in solution.4 The
striking diﬀerence in speciﬁcity for carboxylate versus amide
substrates between the two enzymes is most readily seen in
kcat/Km ratios (Table 1). The structural basis for these kinetics
results is discussed below.
Another assessment of the relative aﬃnity of carboxylate and
amide for the acceptor site can be achieved by studying the
transfer of an acyl group to amine acceptors from a standard
donor. The aminolysis of an acyl−enzyme intermediate should
pass through the same transition states and tetrahedral
intermediate as those from hydrolysis of the original amide
(Scheme 5).
The acyl−enzyme intermediate, however, may be obtained
from another source, hydrolysis of a thiolester, for example. In
the case presented here, the steady state kinetics of aminolysis
of thiolester 15 was studied. Hydrolysis of the acyl−enzyme
intermediate from this substrate at saturation is probably rate-
determining with respect to thiolester hydrolysis because added
amine nucleophiles accelerate the observed rate at substrate
concentrations above Km. An example of this phenomenon is
shown in Figure 2A. The results of such experiments, the
determined k4 values (Scheme 5), are listed in Table 2. Some
amine acceptors at high concentrations also inhibited the
reaction (an example is shown in Figure 2B), most likely by
competition for the donor site (Scheme 5); this phenomenon
has been previously observed.23,27 In such cases, values of K5,
usually quite large (millimolar), are also given in Table 2.
Scheme 4
Table 1. Steady State Parameters for Peptide Hydrolysis by PBP4a and the R39 DD-Peptidase
enzyme parameter substrate 2 substrate 4 substrate 5
PBP4a kcat (s
−1) ≥22a ≥30b ≥8.6
Km (mM) ≥1.0 ≥1.0 ≥1.0
kcat/Km (s
−1 M−1) 2.2 × 104 (3.0 ± 0.3) × 104 (8.6 ± 0.2) × 103
(kcat/Km)/[kcat/Km(2)] 1.0 1.36 0.39
R39 kcat (s
−1) 7.4 ± 0.9c 16 ± 1 ≥1.29
Km (mM) (1.3 ± 0.5) × 10
−3 (30 ± 6) × 10−3 ≥1.0
kcat/Km (s
−1 M−1) 5.76 × 106 5.2 × 105 (1.29 ± 0.03) × 103
(kcat/Km)/[kcat/Km(2)] 1.0 0.09 0.0022
aFrom ref 13. bFrom ref 4. cFrom ref 20.
Scheme 5
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Evident from Table 2 is the much greater eﬃciency of D-
amino acid amides than D-amino acids in reaction with the
acyl−enzyme intermediate derived from reaction of 15 with
PBP4a. D-Lysinamide, the closest analogue to a “real” acceptor
(Figure 1), is particularly eﬀective. The greater eﬀectiveness of
the amide acceptor is more evident in Table 2 than in Table 1.
It may be that the diamide 18 would be an even better PBP4a
substrate than 2, 4, or 5. Further extension of the carboxamide
by N-substitution seemed unlikely to produce acyl acceptors; D-
alanyl-D-alanine, for example (Table 2), was only a weak
inhibitor. We are unaware of a bacterial peptidoglycan in which
amidated diaminopimelic acid is extended through the amide.
In contrast to the results for PBP4a, the R39 enzyme
employed D-amino acid amide acceptors much less eﬀectively
than the amino acids themselves (Table 2). These results for
both enzymes are thus in accord with those from the peptide
hydrolysis experiments described above (Table 1).
Another window into the speciﬁcity of the acceptor site can
be obtained by consideration of the relative reactivities of
penicillin V (16) and its amide (17) with these enzymes (Table
3). It is now accepted that β-lactams such as penicillins are
inhibitors of DD-peptidases to a considerable degree because of
their resemblance to D-Ala-D-Ala-terminated peptides.28,29
Thus, one might expect the carboxylate of a penicillin to bind
at the active side of a DD-peptidase in the same position as that
of the terminal carboxylate of a substrate. Crystal structures
generally support this proposition, at least as far as one can
judge from inert acyl−enzyme structures.10,30
The data of Table 3 show that penicillin V is an excellent
inhibitor of both PBP4a and the R39 DD-peptidase. In the
acylation transition state, the carboxylate group of 16 must ﬁt
well into the active site of both enzymes. As generally expected
from precedent,31,32 the amide 17 is a considerably poorer
inhibitor of both enzymes, but as anticipated from the results
described above, it is a relatively much better inhibitor of
PBP4a than of the R39 DD-peptidase.
The structural basis of the diﬀerent speciﬁcities of PBP4a and
the R39 DD-peptidase for amidated substrates was explored by
molecular modeling. Tetrahedral intermediate models, 19,
derived from the substrates of 4, 5, and 18 were constructed
from the crystal structures of a boronate transition state
analogue complex of the R39 DD-peptidase12 and an acyl−
enzyme complex of PBP4a.13 The initially constructed
structures, where more than one orientation of the amide
group was assessed, were subjected to molecular dynamics
Figure 2. Eﬀect of D-alaninamide (A) and N-ε-acetyl-D-lysine (B) on
initial rates of turnover of the thiolester 15 (0.5 mM), catalyzed by
PBP4a (0.17 μM). The points are experimental, and the lines
represent the ﬁts of the data to Scheme 5 (see the text).
Table 2. Kinetic Parameters for the Aminolysis of 15,
Catalyzed by PBP4a and the R39 DD-Peptidase
enzyme aminea k4 (s
−1 M−1) K5 (mM)
PBP4a D-alanine (300) 63 ± 1.5 130 ± 16
D-alaninamide (400) 1100 ± 220 nob
D-alanyl-D-alanine (280) nob 50 ± 12
D-phenylalanine (80) nob 35 ± 3
D-phenylalaninamide (84) 720 ± 180 nob
glycine (500) nob 300 ± 20
glycinamide (700) 640 ± 300 nob
ε-N-acetyl-D-lysine (94) 490 ± 95 23.4 ± 1.5
D-lysine (25) (3.9 ± 1.8) × 103 nob
D-lysinamide (16) (3.2 ± 1.4) × 104 nob
D-α-aminopimelic acid
(12.5)
150 ± 2 nob
meso-2,6-diaminopimelic acid
(40)
890 ± 200 15.8 ± 0.3
R39 D-alanine (300) 150 ± 74 75 ± 27
D-alaninamide (450) 49 ± 16 nob
D-phenylalanine (80) (7.1 ± 2.3) × 103 nob
D-phenylalaninamide 17 ± 3 nob
glycine (500) 360 ± 100 nob
glycinamide 23 ± 25 nob
aHighest concentration in parentheses. bNot observed under the
conditions employed.
Table 3. Second-Order Acylation Rate Constants for
Inhibition of PBP4a and the R39 DD-Peptidase by β-Lactams
β-lactam PBP4a R39
16 (1.83 ± 0.33) × 105 (2.17 ± 0.30) × 105
17 (4.23 ± 0.02) × 103 (9.1 ± 3.0) × 10
17/16 0.023 0.00042
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simulations as described in Materials and Methods. From these,
structures exhibiting the most favorable interactions with the
respective enzymes were selected for energy minimization,
using interaction energy calculations33 to subsequently choose
between them, where appropriate.
The active sites of PBP4a and the R39 DD-peptidase are very
similar and would be expected to interact with substrates and
their analogues in similar ways.12,13,34 In each case, there is a
strongly interacting oxyanion hole comprising two backbone
NH groups [Ser52 (49) and Thr413 (414); the residue number
of PBP4a is followed in parentheses by that of the
corresponding residue in the R39 DD-peptidase], which is
believed to stabilize anionic tetrahedral intermediates.
All models were initially constructed such that the tetrahedral
oxyanion occupied the oxyanion hole, and those interactions
were, in general, retained. In certain cases, contact between the
ligand and the oxyanion hole was lost during the molecular
dynamics run; such structures were considered nonproductive.
Other active site functional groups that either interact with
speciﬁc substrates or are believed to be directly involved in
catalysis are listed in Table 4, where they are subdivided into
those interacting with the acyl-donor segment of the substrate
and those interacting with the acyl-acceptor/leaving group. The
details of these interactions and their putative participation in
catalysis have been discussed previously.12,13
The superimposition diagram of Figure 3 emphasizes the
point made above concerning the similarity of the PBP4a and
R39 DD-peptidase active sites. Two diﬀerences in active site
residues between them, whose interactions with substrates
might change on amidation of the latter (1a vs 1b), are
apparent in Table 4 and Figure 3. The replacement of Thr413
in the R39 DD-peptidase with serine (414) in PBP4a may aﬀect
interaction with 4 because the terminal carboxylate groups of β-
lactams34 and, most likely, substrates12 interact with both
Thr411 and Thr413 of the R39 DD-peptidase, and with their
analogues in other PBP structures.3 It seems unlikely, however,
that the mutation of Thr413 is speciﬁc for carboxamide binding
because the equivalent of Ser413 is found in most LMMC
enzymes, e.g., in Escherichia coli and other Gram-negative
species where diaminopimelic acid amidation does not usually
occur. More striking is the replacement of Arg351 with
histidine (His352) in the acyl-donor site. The side chain of
histidine, of course, may be cationic, like that of arginine, or
neutral, depending on its pKa and the pH of the medium.
To obtain evidence for the pKa of His352 of PBP4a, the
variation of the Ki value of the product inhibitors 20 and 21 was
determined as a function of pH (Table 5). The product 20
from 2 is known to occupy the donor site of the R39 DD-
peptidase11 and is likely to do so for PBP4a also.13 The Ki value
of neither 20 nor 21 shows signiﬁcant variation between pH 7.5
and 8.8. This suggests the absence of a pKa of His352 in this
region, and thus the likelihood that its pKa is below 7.5. The
increase in Ki for 20 at pH 6.0 probably reﬂects the inﬂuence of
the increase of Km of the substrate below pH 7.5.
23 The
apparently greater increase in Ki of 21 than 20 suggests that the
former inhibitor binds even more weakly to the protonated
form of the enzyme than does the latter. These data are
interpreted to mean that His352 contains a neutral imidazole
moiety at neutral pH. The structural models below, taken
together with the kinetic data provided above, support this
proposition.
Table 4. Active Site Residues of PBP4a and the R39 DD-
Peptidase in Contact with Speciﬁc Substrates
R39 PBP4a












Figure 3. Superimposition of the backbone atoms of the active site
residues of PBP4a (atomic colors) onto those of the R39 DD-peptidase
(turquoise). Only heavy atoms are shown.
Table 5. Inhibition of PBP4a by 20 and 21 as a Function of
pH
Ki (mM)
inhibitor pH 6.0 pH 7.5 pH 8.8
20 0.9 ± 0.1 0.28 ± 0.08 0.48 ± 0.08
21 >5 0.24 ± 0.06 0.38 ± 0.04
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Figure 4 shows structures of peptides 4 (Figure 4A) and 5
(Figure 4B) in the PBP4a active site where His352 is presumed
to be neutral. These models show that both the CO2
− and
CONH2 groups interact well with the acyl-donor site. The
carboxylate of 5 interacts directly [potential hydrogen bonds
(see Figure 4B)] with Ser416, with both the NH and the OH
moieties. It does not seem to interact signiﬁcantly with His352.
On the other hand, the carboxamide of 4 interacts (NH-π) with
the neutral imidazole of His352 (Figure 4A). If His352 were
cationic, however, the carboxylate of 5 would interact tightly
with it (electrostatic) but the amide of 4 less so (Figure 5). The
structure in Figure 5 also shows the distortion of the β-3 strand
(which supports one element of the oxyanion hole) that occurs
throughout the molecular dynamics simulation. This suggests
protein-mediated interaction between the acyl-donor and
-acceptor sites, an issue that has previously been raised from
Figure 4. Stereoviews of energy-minimized tetrahedral intermediate structures (19) formed upon reaction of speciﬁc tripeptide substrates with
PBP4a. The side chain of His352 is neutral. Only heavy atoms are shown except for hydrogens on the imidazole nitrogens of His352. (A) Peptide 4
and (B) peptide 5.
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observations of crystal structures containing speciﬁc sub-
strates.35 The analogous R39 DD-peptidase models (Figure S1
of the Supporting Information) also seem to show a less
eﬀective interaction of the amide of 4 than the carboxylate of 5
with the cationic (Arg351) donor site. Hence, the replacement
of Arg351 of the R39 DD-peptidase, which in vivo would only
come into contact with carboxylate substrates, with the neutral
(at pH 7) imidazole of His352 of PBP4a appears to be a
substitution favored by evolution to produce an enzyme that
might have to process both carboxylate and amidated
substrates. Models containing diamide 18 also show a snug
ﬁt into the enzyme active site when the histidine is neutral
(Figure S2 of the Supporting Information). Figure 4B also
shows that the amide group of 5 interacts well in the acceptor
site, with apparent hydrogen bonds to the side chains of
Ser299, Lys411, and Ser414.
Arg351 of the R39 DD-peptidase appears to be essentially
completely conserved through LMMC DD-peptidases, most of
which interact with peptidoglycan carboxylates. FASTA
searches suggest that the histidine mutation is largely conﬁned
to Bacillus sp. where diaminopimelate amidation might be
expected.14,36 A variety of other enzymes are required to
distinguish carboxylate and carboxamide groups, and many of
them use a strategy similar to that described above. For
example, certain amino acid aminotransferases employ an
arginine to accommodate a substrate γ-carboxylate and neutral
ligands to accommodate an analogous γ-amide.37 The class I E.
coli glutaminyl-tRNA synthetase employs neutral ligands for the
substrate γ-amide but an arginine to divert a γ-carboxylate into
a nonproductive complex.38 As an example, closer to home,
orthologues of LMMA E. coli PBP5 and PBP6 appear to use a
conserved arginine to bind the α-glutamyl carboxylate of
peptidoglycan substrates.39 On the other hand, orthologues of
PBP3 of Streptococcus pneumoniae, also LMMA DD-peptidases,
seem to have neutral ligands in the analogous position to
interact with the α-glutaminyl carboxamides of their
peptidoglycan.
The results described above strongly suggest that the PBP4a
DD-peptidase of B. subtilis is adapted to eﬃciently catalyze
reactions of peptidoglycan fragments containing both D-
aminocarboxylate and D-aminocarboxamide termini. In vivo,
therefore, this enzyme may well have a dual role, evolutionarily
selected by the presence of both termini in the peptidoglycan of
B. subtilis at diﬀerent phases of growth.14,18 PBP4a is thought to
generally act as an endopeptidase in vivo.4,25 In contrast, the
R39 DD-peptidase, another LMMC enzyme, seems strongly
adapted to a single peptidoglycan structure. In principle,
inhibitor design could take advantage of the kind of dual
speciﬁcity found in PBP4a to target particular enzymes or
particular stages of the cell cycle. Design of DD-peptidase
inhibitors based on speciﬁc elements of peptidoglycan structure
remains an attractive goal, but not one easily achieved.3,40 The
aﬃnity of other B. subtilis PBPs, including the essential HMM
enzymes, for carboxamide termini is an interesting issue, and
one that we are currently investigating.
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